The PCR test and the Lateral flow test are diagnostic for active Covid19 disease and for Covid19 transmission?

Katon bouzalakos made this Freedom of Information request to Medicines and Healthcare Products Regulatory Agency Automatic anti-spam measures are in place for this older request. Please let us know if a further response is expected or if you are having trouble responding.

Medicines and Healthcare Products Regulatory Agency did not have the information requested.

Dear Medicines and Healthcare Products Regulatory Agency,

The PCR test and the Lateral flow test are diagnostic for active Covid19 disease and for Covid19 transmission?

Yours faithfully,

Katon bouzalakos

MHRA Customer Services, Medicines and Healthcare Products Regulatory Agency

Our Ref: FOI 23/804

Dear Katon bouzalakos,

RE: REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000

Thank you for your enquiry which we received on 23 October.

I confirm that your request is now being handled under the Freedom of Information Act and you should receive a reply within 20 working days from our date of receipt.

If you need to contact us again about this request, please quote the reference number above.

Please be aware that we publish FOIs replies and these are redacted and are located on our website at the following link below.
https://www.gov.uk/government/collection...

Kind Regards,

MHRA Customer Experience Centre
Communications and engagement team
Medicines and Healthcare products Regulatory Agency
10 South Colonnade, Canary Wharf,
London E14 4PU
Telephone 020 3080 6000

show quoted sections

MHRA Customer Services, Medicines and Healthcare Products Regulatory Agency

FOI 23/804

Dear Katon

Thank you for your email correspondence with our FOI team on 21 October 2023, where you submitted an FOI request for the following:

The PCR test and the Lateral flow test are diagnostic for active COVID-19 disease and for COVID-19 transmission'.

The MHRA does not hold the information requested. To assist with your question, we provide a summary and useful links below:

Polymerase chain reaction (PCR) testing detects the presence of ribonucleic acid (RNA), the genetic material of the SARS-CoV-2 virus. Lateral flow devices (LFDs) detect the presence of an antigen (a type of protein) produced by the SARS-CoV-2 virus when it is active. Both PCR and LFDs are used to detect the active form and non-active form of the disease (asymptomatic individuals), enabling the identification of the population with a transmissible form of the virus.

Please note that the above information is publicly available and can be accessed here:

1. Performance of lateral flow devices during the COVID-19 pandemic - GOV.UK (http://www.gov.uk/)
2. Key points summary: asymptomatic testing for SARS-CoV-2 using antigen-detecting lateral flow devices (evidence from performance data October 2020 to May 2021) - GOV.UK (http://www.gov.uk/)

If you are dissatisfied with the handling of your request, you have the right to ask for an internal review. Internal review requests should be submitted within two months of the date you receive this response and addressed to: [MHRA request email]

Please remember to quote the reference number above in any future communications.

If you were to remain dissatisfied with the outcome of the internal review, you would have the right to apply directly to the Information Commissioner for a decision. Please bear in mind that the Information Commissioner will not normally review our handling of your request unless you have first contacted us to conduct an internal review. The Information Commissioner can be contacted at:

The Information Commissioner's Office
Wycliffe House
Water Lane
Wilmslow
Cheshire
SK9 5AF

The information supplied in response to your request is the copyright of MHRA and/or a third party or parties and has been supplied for your personal use only. You may not sell, resell, or otherwise use any information provided without prior agreement from the copyright holder.

Kind regards,

MHRA Customer Experience Centre
Communications and engagement team
Medicines and Healthcare products Regulatory Agency
10 South Colonnade, Canary Wharf

show quoted sections